Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001969223-25-001044
Filing Date
2025-12-08
Accepted
2025-12-08 10:07:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4123
  Complete submission text file 0001969223-25-001044.txt   5560
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Subject) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39630 | Film No.: 251554928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address
Reich Kristian (Reporting) CIK: 0001920553 (see all company filings)

Type: 144